Literature DB >> 23863881

No impact of lentiviral transduction on hematopoietic stem/progenitor cell telomere length or gene expression in the rhesus macaque model.

Stephanie E Sellers1, Bogdan Dumitriu1, Mary J Morgan1, William M Hughes1, Colin O Wu2, Nalini Raghavarchari3, Yanqin Yang3, Naoya Uchida4, John F Tisdale4, Dong S An5, Irvin S Chen5, Peiman Hematti6, Robert E Donahue1, Andre Larochelle1, Neal S Young1, Rodrigo T Calado1, Cynthia E Dunbar1.   

Abstract

The occurrence of clonal perturbations and leukemia in patients transplanted with gamma-retroviral (RV) vector-transduced autologous hematopoietic stem and progenitor cells (HSPCs) has stimulated extensive investigation, demonstrating that proviral insertions may perturb adjacent proto-oncogene expression. Although enhancer-deleted lentiviruses are less likely to result in insertional oncogenesis, there is evidence that they may perturb transcript splicing, and one patient with a benign clonal expansion of lentivirally transduced HPSC has been reported. The rhesus macaque model provides an opportunity for informative long-term analysis to ask whether transduction impacts on long-term HSPC properties. We used two techniques to examine whether lentivirally transduced HSPCs from eight rhesus macaques transplanted 1-13.5 years previously are perturbed at a population level, comparing telomere length as a measure of replicative history and gene expression profile of vector positive versus vector negative cells. There were no differences in telomere lengths between sorted GFP+ and GFP- blood cells, suggesting that lentiviral (LV) transduction did not globally disrupt replicative patterns. Bone marrow GFP+ and GF- CD34+ cells showed no differences in gene expression using unsupervised and principal component analysis. These studies did not uncover any global long-term perturbation of proliferation, differentiation, or other important functional parameters of transduced HSPCs in the rhesus macaque model.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23863881      PMCID: PMC3978805          DOI: 10.1038/mt.2013.168

Source DB:  PubMed          Journal:  Mol Ther        ISSN: 1525-0016            Impact factor:   11.454


  49 in total

Review 1.  Update on the use of nonhuman primate models for preclinical testing of gene therapy approaches targeting hematopoietic cells.

Authors:  R E Donahue; C E Dunbar
Journal:  Hum Gene Ther       Date:  2001-04-10       Impact factor: 5.695

2.  Telomere measurement by quantitative PCR.

Authors:  Richard M Cawthon
Journal:  Nucleic Acids Res       Date:  2002-05-15       Impact factor: 16.971

3.  Telomere length in haemopoietic stem cells can be determined from that of mononuclear blood cells or whole blood.

Authors:  Jennette A Sakoff; Esther De Waal; Madhu B Garg; James Denham; Fiona E Scorgie; Arno Enno; Lisa F Lincz; Stephen P Ackland
Journal:  Leuk Lymphoma       Date:  2002-10

4.  Telomere shortening in leukocyte subpopulations from baboons.

Authors:  Gabriela M Baerlocher; Jennifer Mak; Alexander Röth; Karen S Rice; Peter M Lansdorp
Journal:  J Leukoc Biol       Date:  2003-02       Impact factor: 4.962

5.  HIV-1 integration in the human genome favors active genes and local hotspots.

Authors:  Astrid R W Schröder; Paul Shinn; Huaming Chen; Charles Berry; Joseph R Ecker; Frederic Bushman
Journal:  Cell       Date:  2002-08-23       Impact factor: 41.582

6.  Lentivirus vector-mediated hematopoietic stem cell gene transfer of common gamma-chain cytokine receptor in rhesus macaques.

Authors:  D S An; S K Kung; A Bonifacino; R P Wersto; M E Metzger; B A Agricola; S H Mao; I S Chen; R E Donahue
Journal:  J Virol       Date:  2001-04       Impact factor: 5.103

7.  Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease.

Authors:  M Cavazzana-Calvo; S Hacein-Bey; G de Saint Basile; F Gross; E Yvon; P Nusbaum; F Selz; C Hue; S Certain; J L Casanova; P Bousso; F L Deist; A Fischer
Journal:  Science       Date:  2000-04-28       Impact factor: 47.728

8.  Prolonged multilineage clonal hematopoiesis in a rhesus recipient of CD34 positive cells marked with a RD114 pseudotyped oncoretroviral vector.

Authors:  Patrick F Kelly; Robert E Donahue; Jody A Vandergriff; Masaaki Takatoku; Aylin C Bonifacino; Brian A Agricola; Mark E Metzger; Cynthia E Dunbar; Arthur W Nienhuis; Elio F Vanin
Journal:  Blood Cells Mol Dis       Date:  2003 Jan-Feb       Impact factor: 3.039

9.  Telomere biology and cellular aging in nonhuman primate cells.

Authors:  Susanne Steinert; Dennis M White; Ying Zou; Jerry W Shay; Woodring E Wright
Journal:  Exp Cell Res       Date:  2002-01-15       Impact factor: 3.905

10.  In vitro aging of macaque adherent cells: similar pattern of cellular aging between human and macaque.

Authors:  Yuko Shimizu; Juri Suzuki; Keiji Terao; Takafumi Ishida
Journal:  Mech Ageing Dev       Date:  2003-02       Impact factor: 5.432

View more
  2 in total

1.  Pigtailed macaques as a model to study long-term safety of lentivirus vector-mediated gene therapy for hemoglobinopathies.

Authors:  Hans-Peter Kiem; Paritha I Arumugam; Christopher R Burtner; Catherine F Fox; Brian C Beard; Phillip Dexheimer; Jennifer E Adair; Punam Malik
Journal:  Mol Ther Methods Clin Dev       Date:  2014-12-17       Impact factor: 6.698

2.  Lentiviral vectors escape innate sensing but trigger p53 in human hematopoietic stem and progenitor cells.

Authors:  Francesco Piras; Michela Riba; Carolina Petrillo; Dejan Lazarevic; Ivan Cuccovillo; Sara Bartolaccini; Elia Stupka; Bernhard Gentner; Davide Cittaro; Luigi Naldini; Anna Kajaste-Rudnitski
Journal:  EMBO Mol Med       Date:  2017-09       Impact factor: 12.137

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.